- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Participating Faculty
The Management of Respiratory Tract Infections:A Focus on Appropriate Antibiotic Utilization
The American Journal of Managed Care
This supplement to contains information about theinfluence of inappropriate antibiotic utilization for the treatment of community-acquired respiratorytract infections, its impact on antimicrobial resistance, and new strategies for optimizingantibiotic utilization.
Faculty
Diana I. Brixner, RPh, PhD
Associate Professor and Chair
Department of Pharmacy Practice
Executive Director, Pharmacotherapy Outcomes
Research Center
University of Utah
Salt Lake City, Utah
David P. Nicolau, PharmD, FCCP
Co-director
Center for Anti-infective Research & Development
Hartford Hospital
Hartford, Connecticut
John A. Sbarbaro, MD, MPH, FCCP
Professor of Medicine and Preventive Medicine
Medical Director, University Physicians, Inc
University of Colorado Health Sciences Center
Denver, Colorado
Disclosure Statement
Faculty members are expected to disclose any real or apparent conflicts of interest that may have adirect bearing on the subject matter of this continuing education activity. Participants have theresponsibility to assess the impact (if any) of the disclosed information on the educational value ofthe activity. The faculty members for this activity have been offered a modest honorarium from theaccredited sponsor for his/her participation in this activity.
The American Journal of Managed Care
It is the policy of to have all faculty who participate inprograms sponsored by corporate organizations disclose any real or apparent conflicts of interest.
These participants have declared the following relationships with corporate organizations:
- Diana I. Brixner, RPh, PhDConsultant and Speakers' Bureau For: Sanofi-Aventis
- David P. Nicolau, PharmD, FCCPGrant/Research Support andSpeakers' Bureau and Consultant For: Abbott Bayer Elan Ortho-McNeil Sanofi-Aventis Wyeth
- John A. Sbarbaro, MD, MPH, FCCPConsultant For: Sanofi-Aventis
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are notindicated by the FDA. The Postgraduate Institute for Medicine (PIM), the Philadelphia College of Pharmacy (PCP),Advanced Concepts Institute (ACI), and Sanofi-Aventis do not recommend the use of any agent outside of thelabeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent theviews of PIM, PCP, ACI, or Sanofi-Aventis. Please refer to the official prescribing information for each product fordiscussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes andtheir own professional development. The information presented in this activity is not meant to serve as a guidelinefor patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggestedin this activity should not be used by clinicians without evaluation of their patient's conditions and possiblecontraindications on dangers in use, review of any applicable manufacturer's product information, and comparisonwith recommendations of other authorities.
The American Journal of Managed Care
Signed disclosures are on file at the offices of , Jamesburg, New Jersey.
